[Drug-induced glomerulonephritis].
Satou
M
M
Koshikawa
S
S
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D005921:Glomerulonephritis / Q000139:chemically induced* / Q000175:diagnosis; D006046:Gold / Q000009:adverse effects*; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D006046:Gold; D010396:Penicillamine